4 results for author:"Harding D.R." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant. Harding D.R., Humphries S.E., Whitelaw A., Marlow N., Montgomery H.E. Arch. Dis. Child. Fetal Neonatal Ed. 92:F108-12(2007) · Mapped (5) |
| Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Monk B.C., Niimi K., Lin S., Knight A., Kardos T.B., Cannon R.D., Parshot R., King A., Lun D., Harding D.R. Antimicrob. Agents Chemother. 49:57-70(2005) · Mapped (1) |
| Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth? Harding D.R., Dhamrait S., Whitelaw A., Humphries S.E., Marlow N., Montgomery H.E. Pediatrics 114:941-947(2004) · Mapped (5) |
| Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Niimi K., Harding D.R., Parshot R., King A., Lun D.J., Decottignies A., Niimi M., Lin S., Cannon R.D., Goffeau A. et al. Antimicrob. Agents Chemother. 48:1256-1271(2004) · UniProtKB (1) · Mapped (2) |